Daily Roundup

RUL.ASX PME.ASX AI1.ASX NHC.ASX ALC.ASX

Rpmglobal Holdings Ltd Moves Forward with Scheme of Arrangement

The Federal Court has approved RPMGlobal Holdings Limited (ASX: RUL) to convene a Scheme Meeting for shareholders to vote on the proposed acquisition of the company by Caterpillar Inc. The Scheme Booklet has been registered with ASIC, and an Independent Expert has concluded that the Scheme is fair and reasonable and in the best interests of RPM Shareholders, in the absence of a Superior Proposal. The RPM Directors unanimously recommend that shareholders vote in favor of the Scheme.

Pro Medicus Signs Major Cloud Imaging Deal

Pro Medicus Limited (ASX: PME) has signed a 5-year, A$44 million contract with Advanced Radiology Management, a leading private radiology group in the US. The deal will see Pro Medicus implement its cloud-based Visage 7 Enterprise Imaging Platform, including the Visage 7 Viewer, across Advanced Radiology Management. This transaction-based model has potential upside and represents further growth in the adoption of Pro Medicus' technology in the North American healthcare market.

Adisyn Achieves Key Milestone in Graphene Deposition Process

Adisyn Ltd (ASX: AI1) has announced a significant technical achievement, successfully validating a critical sub-process within the pre-clean stage of its proprietary low-temperature graphene deposition process. This milestone confirms that Adisyn's process architecture is performing as expected, providing confidence to proceed into the next phase of extensive deposition trials and further process refinement. Adisyn remains on track to deliver progressive technical validation through 2025 and into early 2026.

New Hope Corporation Delivers Solid Quarterly Performance

New Hope Corporation Ltd (ASX: NHC) reported a strong operational and financial performance in the October 2025 quarter. The company saw improved safety metrics, increased coal production and sales volumes, and reduced cash costs at its Bengalla Mine. New Hope also paid a final fully franked dividend of 15.0 cents per share, totaling $126.4 million, to its shareholders.

Alcidion Expands Contract with Leidos Australia

Alcidion Group Limited (ASX: ALC) has expanded its contract with Leidos Australia, adding $12.3 million in total contract value over 2.7 years and $2.5 million in additional annual recurring revenue. Alcidion expects to recognize between $5.5 million and $6.5 million of this new revenue in the 2026 financial year.